![]() |
![]() ![]() |
![]() |
Buy Request | ![]() | Sell Offer | ![]() | Company | ![]() | Reviews | ![]() |
Expire | Country | Pic | Subject | Popularity |
never | ![]() | ![]() | CHO Productivity Assessment | 147 |
never | ![]() | ![]() | Poliovirus Virus-Like Particles (VLPs) | 147 |
never | ![]() | ![]() | Enterovirus 71 (EV71) Virus-Like Particles (VLPs) | 147 |
never | ![]() | ![]() | Virus-Like Particles (VLPs) Production in E. coli System | 147 |
never | ![]() | ![]() | Anti-CTLA4 (Ipilimumab)-MC-MMAF ADC | 147 |
never | ![]() | ![]() | Anti-CSF2RA (Mavrilimumab)-MC-MMAF ADC | 147 |
never | ![]() | ![]() | Anti-CSF2RA (Mavrilimumab)-SMCC-DM1 ADC | 147 |
never | ![]() | ![]() | Anti-CSF2 (Namilumab)-MC-Vc-PAB-SN38 ADC | 147 |
never | ![]() | ![]() | Anti-CSF2 (Namilumab)-MC-MMAF ADC | 147 |
never | ![]() | ![]() | Anti-CSF2 (Namilumab)-SMCC-DM1 ADC | 147 |
Copyright © toextrade Inc. All rights reserved. Contact us |